Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	18
Total, all-cause mortality	Spesolimab 900 mg i.v. SD	0	35
Total, all-cause mortality	Open Label (OL) D8 Spesolimab 900 mg i.v.	0	27
Total, all-cause mortality	Rescue Spesolimab 900 mg i.v.	0	6
Total, other adverse events	Placebo	13	18
Total, other adverse events	Spesolimab 900 mg i.v. SD	23	35
Total, other adverse events	Open Label (OL) D8 Spesolimab 900 mg i.v.	14	27
Total, other adverse events	Rescue Spesolimab 900 mg i.v.	4	6
Total, serious adverse events	Placebo	3	18
Total, serious adverse events	Spesolimab 900 mg i.v. SD	6	35
Total, serious adverse events	Open Label (OL) D8 Spesolimab 900 mg i.v.	6	27
Total, serious adverse events	Rescue Spesolimab 900 mg i.v.	2	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03782792/event-totals